Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.

Vincent I, Jicha G, Rosado M, Dickson DW.

J Neurosci. 1997 May 15;17(10):3588-98.

2.

Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.

Imahori K, Uchida T.

J Biochem. 1997 Feb;121(2):179-88. Review.

3.

Aberrant protein phosphorylation and cytoarchitecture in Alzheimer's disease.

Saitoh T, Iimoto D.

Prog Clin Biol Res. 1989;317:769-80. Review.

PMID:
2690121
4.

Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.

Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J.

Curr Alzheimer Res. 2005 Jan;2(1):3-18. Review.

PMID:
15977985
5.

Alzheimer neurofibrillary lesions: molecular nature and potential roles of different components.

Yen SH, Liu WK, Hall FL, Yan SD, Stern D, Dickson DW.

Neurobiol Aging. 1995 May-Jun;16(3):381-7. Review.

PMID:
7566347
6.

Role of cdk5 in the pathogenesis of Alzheimer's disease.

Lau LF, Ahlijanian MK.

Neurosignals. 2003 Sep-Oct;12(4-5):209-14. Review.

PMID:
14673207
7.

Cdk5 as a drug target for the treatment of Alzheimer's disease.

Lau LF, Seymour PA, Sanner MA, Schachter JB.

J Mol Neurosci. 2002 Dec;19(3):267-73. Review.

PMID:
12540052
8.

Triggering the all-or-nothing switch into mitosis.

O'Farrell PH.

Trends Cell Biol. 2001 Dec;11(12):512-9. Review.

9.

Neuronal cdc2-like kinase.

Lew J, Wang JH.

Trends Biochem Sci. 1995 Jan;20(1):33-7. Review.

PMID:
7878742
10.

Fast axonal transport misregulation and Alzheimer's disease.

Morfini G, Pigino G, Beffert U, Busciglio J, Brady ST.

Neuromolecular Med. 2002;2(2):89-99. Review.

PMID:
12428805
11.
12.

[Regulation of Cdk5 activity in post-mitotic neurons].

Saito T, Hisanaga S.

Seikagaku. 2001 Apr;73(4):276-8. Review. Japanese. No abstract available.

PMID:
11449683
13.

Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development?

Soutar MP, Thornhill P, Cole AR, Sutherland C.

Curr Alzheimer Res. 2009 Jun;6(3):269-78. Review.

PMID:
19519308
14.

Regulation of neuronal cytoskeletal protein phosphorylation in neurodegenerative diseases.

Rudrabhatla P.

J Alzheimers Dis. 2014;41(3):671-84. doi: 10.3233/JAD-130794. Review.

PMID:
24748119
15.

Generation of the Cdk5 activator p25 is a memory mechanism that is affected in early Alzheimer's disease.

Giese KP.

Front Mol Neurosci. 2014 May 1;7:36. doi: 10.3389/fnmol.2014.00036. eCollection 2014. Review.

16.

Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer's disease.

van Leeuwen LA, Hoozemans JJ.

Acta Neuropathol. 2015 Apr;129(4):511-25. doi: 10.1007/s00401-015-1382-7. Epub 2015 Jan 25. Review.

Items per page

Supplemental Content

Write to the Help Desk